FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Heribert Juergens

Research Profile

Physiology

Chemicals & Drugs

Anatomy

Living Beings

Human Herpesvirus 4

Disorders

Procedures

Co-author Network

Publications

TOP 3
Sarah-Kristin Mueller; Martina Ahlmann; Bianca Altvater; Christiane Chen; Uta Dirksen; Heribert Juergens; Sareetha Kailayangiri; Claudia Rossig
Zoledronic acid negatively affects the expansion of in vitro activated human NK cells and their cytolytic interactions with Ewing sarcoma cells.
Manfred Berger; Andreas Braeuninger; Uta Dirksen; Heribert Juergens; Gabriele Koehler; Manuela Krumbholz; Markus Metzler
Genomic EWS-FLI1 fusion sequences in Ewing sarcoma resemble breakpoint characteristics of immature lymphoid malignancies.
Karoline Ehlert; Michael C Fruehwald; Andreas H Groll; Claudia Rossig; Heribert Juergens
Late graft failure in FA--case report and review of the literature.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Heribert Juergens (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Sarah-Kristin Mueller; Martina Ahlmann; Bianca Altvater; Christiane Chen; Uta Dirksen; Heribert Juergens; Sareetha Kailayangiri; Claudia Rossig
Zoledronic acid negatively affects the expansion of in vitro activated human NK cells and their cytolytic interactions with Ewing sarcoma cells.
Oncology reports 2013;29(6):2348-54.
2013: Manfred Berger; Andreas Braeuninger; Uta Dirksen; Heribert Juergens; Gabriele Koehler; Manuela Krumbholz; Markus Metzler
Genomic EWS-FLI1 fusion sequences in Ewing sarcoma resemble breakpoint characteristics of immature lymphoid malignancies.
PloS one 2013;8(2):e56408.
2012: Karoline Ehlert; Michael C Fruehwald; Andreas H Groll; Claudia Rossig; Heribert Juergens
Late graft failure in FA--case report and review of the literature.
Pediatric transplantation 2012;16(8):E360-3.
2012: Bianca Altvater; Heribert Juergens; Sareetha Kailayangiri; Silke Landmeier; Sibylle Pscherer; Barbara Savoldo; Claudia Rossig
Activated human γδ T cells induce peptide-specific CD8+ T-cell responses to tumor-associated self-antigens.
Cancer immunology, immunotherapy : CII 2012;61(3):385-96.
2012: C I-U Chen; J Gerss; Heribert Juergens; L Kerstiens; Steffen Koschmieder; P P Lee; H T Maecker; Sibylle Pscherer; Bianca Altvater; Wolfgang E Berdel; M Schemionek; Claudia Rossig
NK cells are dysfunctional in human chronic myelogenous leukemia before and on imatinib treatment and in BCR-ABL-positive mice.
Leukemia 2012;26(3):465-74.
2011: Heribert Juergens; Luisa Paccagnella; Milena Villarroel; Tao Wang; Jeremy Whelan; Donghua Yin; Isabelle Aerts; Najat C Daw; Uta Dirksen; Stefano Ferrari; Birgit Geoerger; Stephanie Green; Mary L Hixon; Antonio Gualberto
Preliminary efficacy of the anti-insulin-like growth factor type 1 receptor antibody figitumumab in patients with refractory Ewing sarcoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(34):4534-40.
2011: Alberto S Pappo; Shreyaskumar R Patel; Denise K Reinke; Scott M Schuetze; Guy C Toner; Robert S Benjamin; Sant P Chawla; Rashmi Chugh; John Crowley; Kristen N Ganjoo; Birgit Geoerger; Lee Helman; Heribert Juergens; Klaus-Peter Kuenkele; Michael G Leahy; ROBERT G MAKI; Paul A Meyers; Laurence H Baker
R1507, a monoclonal antibody to the insulin-like growth factor 1 receptor, in patients with recurrent or refractory Ewing sarcoma family of tumors: results of a phase II Sarcoma Alliance for Research through Collaboration study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(34):4541-7.
2011: Claudia Rossig; Heribert Juergens; Wolfgang E Berdel
New targets and targeted drugs for the treatment of cancer: an outlook to pediatric oncology.
Pediatric hematology and oncology 2011;28(7):539-55.
2009: Bianca Altvater; Silke Landmeier; Sibylle Pscherer; Jaane Temme; Heribert Juergens; Martin Pule; Claudia Rossig
2B4 (CD244) signaling via chimeric receptors costimulates tumor-antigen specific proliferation and in vitro expansion of human T cells.
Cancer immunology, immunotherapy : CII 2009;58(12):1991-2001.
2009: Peter Brinkrolf; Silke Landmeier; Bianca Altvater; Christiane Chen; Sibylle Pscherer; Annegret Rosemann; Andreas Ranft; Uta Dirksen; Heribert Juergens; Claudia Rossig
A high proportion of bone marrow T cells with regulatory phenotype (CD4+CD25hiFoxP3+) in Ewing sarcoma patients is associated with metastatic disease.
International journal of cancer. Journal international du cancer 2009;125(4):879-86.
2009: Bianca Altvater; Silke Landmeier; Sibylle Pscherer; Jaane Temme; Katharina Schweer; Sareetha Kailayangiri; Dario Campana; Heribert Juergens; Martin Pule; Claudia Rossig
2B4 (CD244) signaling by recombinant antigen-specific chimeric receptors costimulates natural killer cell activation to leukemia and neuroblastoma cells.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(15):4857-66.
2009: K Masjosthusmann; Karoline Ehlert; Bodo R Eing; Johannes Roth; G Koehler; Heribert Juergens; M Fruehwald; Andreas H Groll
Delay in B-lymphocyte recovery and function following rituximab for EBV-associated lymphoproliferative disease early post-allogeneic hematopoietic SCT.
Bone marrow transplantation 2009;43(9):679-84.
2009: Silke Landmeier; Bianca Altvater; Sibylle Pscherer; Heribert Juergens; Lena Varnholt; Anna Hansmeier; Catherine M Bollard; Andreas Moosmann; Guido Bisping; Claudia Rossig
Activated human gammadelta T cells as stimulators of specific CD8+ T-cell responses to subdominant Epstein Barr virus epitopes: potential for immunotherapy of cancer.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2009;32(3):310-21.
2008: Claudia Rossig; Heribert Juergens
Aetiology of childhood acute leukaemias: current status of knowledge.
Radiation protection dosimetry 2008;132(2):114-8.
2007: Silke Landmeier; Bianca Altvater; Sibylle Pscherer; Bodo R Eing; Joachim Kuehn; Cliona M Rooney; Heribert Juergens; Claudia Rossig
Gene-engineered varicella-zoster virus reactive CD4+ cytotoxic T cells exert tumor-specific effector function.
Cancer research 2007;67(17):8335-43.
2006: Bianca Altvater; Sibylle Pscherer; Silke Landmeier; V Niggemeier; Heribert Juergens; Josef Vormoor; Claudia Rossig
CD28 co-stimulation via tumour-specific chimaeric receptors induces an incomplete activation response in Epstein-Barr virus-specific effector memory T cells.
Clinical and experimental immunology 2006;144(3):447-57.
2006: Stefan Gattenlöhner; Alexander Marx; Birgit Markfort; Sibylle Pscherer; Silke Landmeier; Heribert Juergens; Hans Konrad Müller-Hermelink; Ian Matthews; David Beeson; Angela Vincent; Claudia Rossig
Rhabdomyosarcoma lysis by T cells expressing a human autoantibody-based chimeric receptor targeting the fetal acetylcholine receptor.
Cancer research 2006;66(1):24-8.
2005: Willi Woessmann; Kathrin Seidemann; Georg Mann; Martin Zimmermann; Birgit Burkhardt; Ilske Oschlies; Wolf-Dieter Ludwig; Thomas Klingebiel; Norbert Graf; Bernd Gruhn; Heribert Juergens; Felix Niggli; Reza Parwaresch; Helmut Gadner; Hansjörg Riehm; Martin Schrappe; Alfred Reiter
The impact of the methotrexate administration schedule and dose in the treatment of children and adolescents with B-cell neoplasms: a report of the BFM Group Study NHL-BFM95.
Blood 2005;105(3):948-58.
2002: C Roessig; S P Scherer; A Baer; Josef Vormoor; Cliona M Rooney; M K Brenner; Heribert Juergens
Targeting CD19 with genetically modified EBV-specific human T lymphocytes.
Annals of hematology 2002;81 Suppl 2():S42-3.